ArticleExpert opinion on biological therapy2017

Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders.

Rabih Said et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.